Mixed Picture for Stocks, Covid-19 Hot Spots, Gilead’s Remdesivir Price Tag, Facebook Ad Fallout

Carl Quintanilla, Jim Cramer and David Faber discuss the move in the major averages, higher to start the week, as investors shrugging off a surge in coronavirus cases across the United States. Health & Human Services Secretary Alex Azar warning Sunday that the “window is closing” to curb the spread of the virus and get the outbreak under control. Confirmed cases across the globe topping 10 million, with global deaths passing half a million. Plus, Gilead announcing its coronavirus treatment Remdesivir’s price tag. It will cost $3,120 per U.S. patient with private insurance. Major advertising fallout for Facebook. Over the weekend, Starbucks, Coca-Cola, Diageo and Hershey’s all announced they’re pausing social media ads in the latest action against hate speech on platforms like Facebook and Twitter. Plus, a pioneer in the U.S. shale revolution, Chesapeake Energy, filing for bankruptcy protection. The company announcing $7 billion in debt will be wiped out through its restructuring.